On October 30, 2026, the Canadian Intellectual Property Office (CIPO) announced that it is seeking the public’s feedback on proposed changes to the Manual of Patent Office Practice (MOPOP) relating to patentable subject-matter.

Patentable subject-matter refers to the types of inventions eligible for patent protection. An invention must satisfy certain requirements under the Patent Act (the Act) to be considered patentable.  The MOPOP provides guidance to patent examiners, applicants, agents, and the public on how CIPO examines patent applications and applies its operational procedures.

CIPO is proposing substantive updates to four chapters of the MOPOP to provide guidance on purposive construction and the assessment of patentable subject-matter, as summarized below:

  • Chapter 12 – Fundamentals of Examination: addresses the examination of patent applications. The proposed changes include, among other things, updates to the MOPOP’s guidance for examination of a patent application using the purposive construction of its claims and prior art searches.
  • Chapter 17 – Subject-Matter: addresses the requirements for determining whether an invention constitutes patentable subject-matter under the Act. The proposed revisions provide updated guidance on assessing patentability, including, the requirement for physicality and the exclusion of abstract ideas and scientific principles.
  • Chapter 22 – Computer- Implemented Inventions: addresses the patentability of computer-implemented inventions. The proposed changes clarify how computer-implemented inventions are assessed, including, among other things, the distinction between patentable practical applications and non-patentable abstract subject-matter.
  • Chapter 23 – Biotechnology and Medicinal Inventions: covers patent applications relating to biotechnology and medical inventions. The proposed revisions provide updated guidance on patentable subject-matter in these areas, including methods of medical treatment.

In addition to these substantive updates, CIPO is proposing minor amendments to Chapter 16 (Claims) and Chapter 19 (Utility). The proposed changes across all six chapters incorporate guidance from CIPO’s March 2026 Practice Notice on Patentable Subject-Matter under the Patent Act and reflect the Supreme Court of Canada's decision in Pharmascience Inc. v. Janssen Inc., 2026 SCC 26 (as previously reported by the E-TIPS® Newsletter here and here).

The consultation is open to the public until Friday, December 18, 2026. For more information on the consultation, the proposed revisions and how to submit comments, see here.

Summary By: Victoria Di Felice

 

E-TIPS® ISSUE

26 11 18

Disclaimer: This Newsletter is intended to provide readers with general information on legal developments in the areas of e-commerce, information technology and intellectual property. It is not intended to be a complete statement of the law, nor is it intended to provide legal advice. No person should act or rely upon the information contained in this newsletter without seeking legal advice.

E-TIPS is a registered trade-mark of Deeth Williams Wall LLP.